Cambridge Cardiovascular Annual Research Symposium - April 2021

Online event

When Symptoms Don't Stop

Treating those most severely affected by COVID-19 has necessarily taken priority during the pandemic. But could long COVID be the next wave of the crisis?

Our hearts and minds are more closely linked than we thought, suggests University of Cambridge study

Professor Emanuele Di Angelantonio, BHF-funded researcher at the University of Cambridge, said: “This is the largest evidence to date that feelings related to depression are associated with a person’s chance of having heart disease or stroke in the future.

SIRT6 Protects Smooth Muscle Cells from Senescence and Reduces Atherosclerosis

SIRT6 protein expression is reduced in human and mouse plaque VSMCs and is positively regulated by CHIP. SIRT6 regulates telomere maintenance and VSMC lifespan, and inhibits atherogenesis, all dependent on its deacetylase activity. Our data shows that endogenous SIRT6 deacetylase is an important and unrecognized inhibitor of VSMC senescence and atherosclerosis.

Policy, Scientific Advocacy, and Combatting Obesity- workshop outcome

The United Kingdom is one of the most obese countries in the world, with more than two-thirds of adults overweight. The covid-19 pandemic has brought increased attention to the obesity epidemic, as being overweight increases the risk of hospitalization or death due to the virus. With this context in mind, CSaP convened an expert panel and a group of early career researchers from the Cambridge Metabolic Network and the Cardiovascular Interdisciplinary Research Centre to explore the role of scientific advice and advocacy in responding to the UK's obesity epidemic.

Scientists to improve heart attack treatment by blocking heart damaging molecules

Scientists in Cambridge are to investigate how the treatment of heart attacks could be improved.

Lack of understanding of common heart condition leads to missed treatment opportunities, study suggests

Poor awareness of a condition known as Heart Failure with preserved Ejection Fraction (HFpEF) – the cause of a half of all cases of heart failure in England – could be hindering opportunities to improve care for patients, say researchers from the Universities of Cambridge, Manchester, and Keele.